Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis

Pediatric Nephrology

Volumn 22, Issue 6, 2007, Pages 889-892

  Kawasaki, Yukihiko ^a   Suzuki, Sigeo ^a   Matsumoto, Ayumi ^a   Takano, Kei ^a   Suyama, Kazuhide ^a   Hashimoto, Koichi ^a   Suzuki, Junzo ^a   Suzuki, Hitoshi ^a   Hosoya, Mitsuaki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Children; FSGS; LDLapheresis; Long termoutcome

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CYCLOSPORIN A; IMMUNOGLOBULIN M; LIPID; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE; PRAVASTATIN; PREDNISOLONE; TRIACYLGLYCEROL; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN;

APHERESIS; ARTICLE; CASE REPORT; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BIOPSY; MALE; MICROSCOPY; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; BLOOD COMPONENT REMOVAL; DRUG RESISTANCE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYPERLIPIDEMIAS; KIDNEY GLOMERULUS; LIPOPROTEINS, LDL; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; TREATMENT OUTCOME;

EID: 34247380209     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0426-6     Document Type: Article

References (18)

1. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218
2. Brown CR, Cameron JS, Turner DR, Chantler C, Ogg CS, Williams DG, Bewick M (1978) Focal segmental glomerulosclerosis with rapid decline in renal function (malignant FSGS). Clin Nephrol 10:51-61
3. Moorhead JF, Chan MK, EL-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 11:1309-1311
4. Diamond JR, Karnovsky M (1988) Focal segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33:917-924
5. D'Amico G, Gentile M, Manna G, Fellin G, Ciceri R, Cofano F, Petrini C, Lavarda F, Perolini S, Porrini M (1992) Effect of vegetarian soy diet on hyperlipidemia in nephritic syndrome. Lancet 339:1131-1134
6. Hattori M, Ito K, Kawaguchi H, Tanaka T, Kubota R, Khono M (1993) Treatment with a combination of low-density lipoprotein apheresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis. Pediatr Nephrol 7:196-198
7. Kasiske BL, Vclosa J, Halstenson CE, La Belle P, Langendorfer A, Keane WF (1990) The effects of lovastatin in hyperlipidemic patients with nephritic syndrome. Am J Kidney Dis 15:8-15
8. Muso E, Masatoshi M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y, and the Kansai FGS LDL Apheresis Treatment (K-FLAT) Study Group (2000) Significantly rapid relief from steroid-resistant nephritic syndrome by LDL apheresis compared with steroid monotherapy. Nephron 89:408-415
9. Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K (2003) A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 42:1121-1130
10. Gordon BR, Kelsey S, Biheimer DW, Brown DC, Dau PC, Gotto AM, Jones PH, Leitman SF, Prihoda J, Stein EA, Stern TN, Zavotal JH, Zwicner RJ (1992) Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose absorption system. Am J Cardiol 70:1010-1016
11. Thompson GR, Miller JP, Breslow JL (1985) Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. BMJ 291:1621-1623
12. Korbet SM (1998) Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9:1333-1340
13. Korbet SM, Schwartz MM, Lewis EL (1998) Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23:773-783
14. Kojima S, Harada-Shiba M, Toyota Y, Kimura G, Tsushima M, Kuramochi M, Sakata T, Uchida K, Yamamoto A, Omae T (1992) Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 15:185-190
15. Stenvinkel P, Alvestrand A, Angelin B, Eriksson M (2000) LDL-apheresis in patients with nephritic syndrome: Effects on serum albumin and urinary albumin excretion. Eur J Clin Invest 30:866-870
16. Cheong Hae II, Lee JH, Hahn H, Park HW, Ha IIS, Choi Y (2001) Circulating VEGF and TGF-B1 in children with idiopathic nephritic syndrome. J Nephrol 14:263-269
17. Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89:342-347
18. Nakamura T, Kawagoe Y, Ogawa H, Ueda Y, Hara M, Shimada N, Ebihara I, Koide H (2005) Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephritic syndrome due to diabetic nephropathy. Am J Kidney Dis 45:48-53